Interestingly, immune PD‐L1 expression was significantly upregulated only in the patients with early recurrence, indicating that the increased PD‐L1 expression in immune cells may be involved in early but not late recurrence of HNSCC (Figure S3 and Table S6). This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.